← All indications
Lipidoses
Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved.
Subtype terms (4)
More specific conditions that are subtypes of Lipidoses in the MeSH hierarchy.
- Cholesterol Ester Storage Disease
1 drug approved
- Neuronal Ceroid-Lipofuscinoses
18 drugs (6 approved, 12 experimental)
- Sjogren-Larsson Syndrome
2 drugs experimental
- Sphingolipidoses
9 drugs (7 approved, 2 experimental)
Drugs by status
Phase 2 trials (1)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Other Experimental Indications (4)